MyFinsight
Home
Blog
About
cencora-logo-svg
Cencora, Inc. (COR)
cencora-logo-svg
Cencora, Inc. (COR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$628,695K
Free Cash flow
$2,428,021K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Borrowings under revolving and s...
Accounts payable
Net income
Others
Negative Cash Flow Breakdown
Repayments under revolving and s...
Purchases of common stock
Inventories
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
776,667
1,629,528
566,126
-333,071
Depreciation, including amounts charged to cost of goods sold
154,410
142,302
135,247
133,728
Amortization, including amounts charged to interest expense
123,018
120,675
129,024
130,270
Provision for credit losses
11,721
-4,885
13
17,792
Provision for deferred income taxes
54,884
178,407
14,362
55,389
Share-based compensation expense
28,733
28,002
66,054
25,943
Lifo credit
-94,304
-210,030
-77,562
-56,962
Trkiye highly inflationary impact
15,724
10,474
8,723
12,660
Impairment of assets, including goodwill
0
0
249,498
837,378
Adjustments to rca and oneoncology equity units
55,167
55,445
-32,783
-
Adjustments-Contingent Consideration Equity Units
-
-
-
121,666
Remeasurement gain related to oneoncology acquisition (note 2)
0
1,086,612
-
-
Adjustments-Contingent Consideration Predefined Business Objective
-
-
-
19,550
(gain) loss on divestiture of businesses
17,247
0
0
0
Gain on remeasurement of equity investment
-6,000
0
10,501
-16,501
Gain on divestiture of equity investment
0
-
-
0
Gain on sale of assets
-1,282
234
35,816
-
Other, net
13,800
5,681
-6,726
3,594
Accounts receivable
445,946
-522,077
830,752
945,803
Inventories
886,857
-3,399,637
3,519,839
319,548
Prepaid expenses and other assets
-107,734
-68,490
14,386
63,957
Accounts payable
2,827,267
-3,501,753
1,307,868
3,755,256
Accrued expenses
36,138
70,971
-328,365
-21,131
Income taxes payable and other liabilities
17,363
-78,174
-13,726
-86,278
Long-term accrued litigation liability
-103,894
-
-
-404,102
Net cash provided by operating activities
2,654,060
1,338,639
-2,305,169
3,133,417
Capital expenditures
226,039
165,618
119,376
249,812
Cost of acquired companies, net of cash acquired
41,660
4,712,350
219,686
91,410
Proceeds from sale of assets
2,043
717
43,057
-
Proceeds from divestiture of a business
25,000
-
-
-
Cost of equity investments
9,269
8,500
10,710
2,450
Non-customer note receivable
2,813
20,626
0
34,814
Other, net
-6,963
9,776
-7,400
-21,732
Net cash used in investing activities
-240,149
-4,874,901
-299,315
-321,940
Senior notes and loan borrowings
39,328
4,540,483
107,720
0
Senior notes and loan repayments
719,646
217,784
131,709
517,203
Borrowings under revolving and securitization credit facilities
12,884,288
47,212,956
23,791,590
45,980,788
Repayments under revolving and securitization credit facilities
12,852,175
47,424,106
23,501,389
46,045,822
Purchases of common stock
1,000,052
0
0
0
Exercises of stock options
-
-
7,598
6,520
Cash dividends on common stock
116,589
117,456
126,516
107,512
Employee tax withholdings related to restricted share vesting
138
7,035
98,151
109
Other, net
-2,841
-893
-5,939
-444
Net cash provided by financing activities
-1,767,825
3,978,567
43,204
-683,782
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
-10,694
9,751
-24,576
-8,472
Decrease in cash, cash equivalents, and restricted cash, including cash classified within assets held for sale
635,392
-2,133,800
-
-
Less increase in cash classified within assets held for sale
-6,697
-24,487
-
-
Decrease in cash, cash equivalents, and restricted cash
628,695
427,569
-2,585,856
2,119,223
Cash, cash equivalents, and restricted cash at beginning of period
1,808,693
1,808,693
4,394,549
3,394,974
Cash, cash equivalents, and restricted cash at end of period
2,864,957
2,236,262
1,808,693
4,394,549
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts payable
$2,827,267K
(365.33%↑ Y/Y)
Net income
$776,667K
(12.60%↑ Y/Y)
Depreciation, including
amounts charged to cost...
$154,410K
(18.45%↑ Y/Y)
Amortization, including
amounts charged to...
$123,018K
(-4.35%↓ Y/Y)
Prepaid expenses and
other assets
-$107,734K
(24.95%↑ Y/Y)
Adjustments to rca and
oneoncology equity units
$55,167K
(47.27%↑ Y/Y)
Provision for deferred
income taxes
$54,884K
(429.48%↑ Y/Y)
Accrued expenses
$36,138K
(-79.09%↓ Y/Y)
Share-based compensation
expense
$28,733K
(23.93%↑ Y/Y)
Income taxes payable
and other...
$17,363K
(-4.88%↓ Y/Y)
Trkiye highly
inflationary impact
$15,724K
(-6.40%↓ Y/Y)
Provision for credit
losses
$11,721K
(-64.65%↓ Y/Y)
Gain on
remeasurement of equity...
-$6,000K
(-122.01%↓ Y/Y)
Gain on sale of assets
-$1,282K
Net cash provided by
operating activities
$2,654,060K
(2329.41%↑ Y/Y)
Canceled cashflow
$1,562,048K
Decrease in cash, cash
equivalents, and restricted...
$635,392K
Canceled cashflow
$2,018,668K
Inventories
$886,857K
(-9.88%↓ Y/Y)
Accounts receivable
$445,946K
(-41.29%↓ Y/Y)
Long-term accrued
litigation liability
-$103,894K
Lifo credit
-$94,304K
(-81.15%↓ Y/Y)
(gain) loss on
divestiture of businesses
$17,247K
Other, net
$13,800K
(-65.30%↓ Y/Y)
Borrowings under revolving
and securitization...
$12,884,288K
(-69.70%↓ Y/Y)
Senior notes and loan
borrowings
$39,328K
(-96.69%↓ Y/Y)
Proceeds from
divestiture of a business
$25,000K
Other, net
-$6,963K
(-12.31%↓ Y/Y)
Non-customer note receivable
$2,813K
Proceeds from sale of
assets
$2,043K
Decrease in cash, cash
equivalents, and restricted...
$628,695K
(549.75%↑ Y/Y)
Canceled cashflow
$6,697K
Net cash provided by
financing activities
-$1,767,825K
(-920.40%↓ Y/Y)
Net cash used in
investing activities
-$240,149K
(-2.33%↓ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$10,694K
(-259.14%↓ Y/Y)
Canceled cashflow
$12,923,616K
Canceled cashflow
$36,819K
Less increase in cash
classified within assets...
-$6,697K
Repayments under revolving
and securitization...
$12,852,175K
(-70.23%↓ Y/Y)
Capital expenditures
$226,039K
(23.37%↑ Y/Y)
Cost of acquired
companies, net of cash...
$41,660K
(-26.21%↓ Y/Y)
Purchases of common stock
$1,000,052K
Senior notes and loan
repayments
$719,646K
(234.96%↑ Y/Y)
Cash dividends on
common stock
$116,589K
(8.46%↑ Y/Y)
Other, net
-$2,841K
(53.77%↑ Y/Y)
Employee tax
withholdings related to...
$138K
(18.97%↑ Y/Y)
Cost of equity
investments
$9,269K
(662.25%↑ Y/Y)
Buy us a coffee